Therefore, to demonstrate further that ADAM9 acts as the target molecule of USP39 in the regulation of glioma cell migration and invasion, we examined the expression levels of integrin β1 in the shUSP39‐U251 cells in vitro and in vivo. Here, ADAM9 is linked to central nervous system cancer.